Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.
Sancho-Saldaña A, Gil Sánchez A, Quirant-Sánchez B, Nogueras L, Peralta S, Solana MJ, González-Mingot C, Gallego Y, Quibus L, Ramo-Tello C, Presas-Rodríguez S, Martínez-Cáceres E, Torres P, Hervás JV, Valls J, Brieva L.
Sancho-Saldaña A, et al. Among authors: quirant sanchez b.
J Clin Med. 2022 Apr 29;11(9):2509. doi: 10.3390/jcm11092509.
J Clin Med. 2022.
PMID: 35566632
Free PMC article.